SEC Form 4 · accession 0001209191-18-032768
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pat Cotroneo
Officer — SVP, Finance and CFO
Period of report
May 21, 2018
Accepted (ET)
May 23, 2018 · 7:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 21, 2018 | M | 7,987 | $19.39 | A | 239,291 | D | |
| Common StockF1 | May 21, 2018 | M | 7,000 | $25.40 | A | 246,291 | D | |
| Common StockF2,F3,F1 | May 21, 2018 | S | 14,987 | $55.04 | D | 231,304 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $19.39 | May 21, 2018 | M | 7,987 | D | — | Feb 22, 2026 | Common Stock | 7,987 | 38,013 | D |
| Stock Option (Right to Buy)F4 | $25.40 | May 21, 2018 | M | 7,000 | D | — | Mar 8, 2027 | Common Stock | 7,000 | 58,000 | D |
Explanation of responses
- F1Includes 1,420 shares purchased through the Issuer's ESPP on May 15, 2018.
- F2Shares sold pursuant to a 10b5-1 plan.
- F3The shares were sold at prices ranging from $55.00 to $55.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years.